Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.

Boral, Baris; Balli, Hüseyin Tugsan; Sözütok, Sinan; Pehlivan, Umur Anil; Aikimbaev, Kairgeldy

Boral, Baris; Balli, Hüseyin Tugsan; Sözütok, Sinan; Pehlivan, Umur Anil; Aikimbaev, Kairgeldy.

Affiliation

Boral B; Department of Immunology, Adana Health Practice and Research Center, University of Health Sciences, Adana, Turkey.
Balli HT; Department of Radiology, Çukurova University School of Medicine, Adana, Turkey.
Sözütok S; Department of Radiology, Çukurova University School of Medicine, Adana, Turkey.
Pehlivan UA; Department of Radiology, Çukurova University School of Medicine, Adana, Turkey.
Aikimbaev K; Department of Radiology, Çukurova University School of Medicine, Adana, Turkey.

Scand J Immunol ; 95(3): e13132, 2022 Mar.

Article de En | MEDLINE | ID: mdl-34936119

Sujet(s)
Mots clés

M-MDSC; T cells; cancer; neutrophils

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Antigènes HLA-DR / Carcinome hépatocellulaire / Antigènes CD14 / Cellules myéloïdes suppressives / Tumeurs du foie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Scand J Immunol Année: 2022 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google